Study Information
Status: Completed
Locations
Palo Alto/Santa Cruz
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
An open-label, single-arm study to evaluate the effectiveness and safety of ocrelizumab in patients with early stage relapsing remitting multiple sclerosis.
Principal Investigator
Funder
Genentech, Inc.
Related Studies
GXCA
Gene Expression of Cerebral Aneurysms // [EMC]
Investigator: Lawrence Dickinson, M.D
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Use EHRs and survey data to characterize migraineurs at Sutter Health by demographic, comorbidity, symptom, and care gap profiles, to see if tx needs are met.
Mindfulness and Migraine: A Randomized Controlled Trial
Conduct a randomized controlled feasibility trial of mindfulness-based stress reduction for patients with moderate-to-severe migraine headache.
Investigator: Sylvia Sudat, PhD
Genetics and Comorbidity of Migraine
Identify common genetic variants for migraine to determine whether there are single nucleotide polymorphisms associated with migraine.